Since high levels of Tks5 expression were found to be correlated with poor patient outcome in cases of invasive stage I and II breast cancer, the effects of Tks5 knockdown were investigated on orthotopic growth of MDA-MB-231 human breast cancer cells in SCID-Beige mice [29]. Here, SH3PXD2A is linked to breast carcinoma.